[308 Pages Report] In 2022, the global intraoperative radiation therapy systems market is expected to be worth US$ 55.9 million. The application of therapeutic stages of radiation to the tumour site is known as IORT. IORT is frequently used in the multidisciplinary treatment of privately advanced and recurring disease, alongside outer beam radiation, chemotherapy, and surgery. Intraoperative …
Category Archives: Healthcare Trends
Insulin Biosimilars Market to expand at a 14.9% value CAGR by 2032 | Says FMI Analyst
Global Insulin Biosimilars Market demand is anticipated to be valued at US$ 1,468.6 Million in 2022, forecast a CAGR of 14.9% to be valued at US$ 5,876.4Million from 2022 to 2032. Growth is attributed to increase in the number of diabetic patients globally. From 2016-2021 a CAGR of 21.5% was registered for the insulin biosimilars market. The COVID-19 pandemic has been posing measurable impact on the …
Anemia Treatment Market Size to Reach US$ 14.9 Billion by 2028 | CAGR of 6.9% By FMI
The global Anemia therapy market is expected to exceed US$ 10.0 billion in 2022. The market is expected to be worth US$ 14.9 billion by 2028, with sales increasing at a robust 6.9% CAGR. Most of the demand for anemia treatment is driven by the condition as a result of one or more chronic diseases, according to a new research study by Future …
Anti-Ageing Products Services and Devices Market is Predicted to Reach Approximately US$ 369.76 Billion by 2031
According to Future Market Insights (FMI), demand for anti-aging products, services, and technologies is expected to grow at a CAGR of more than 5.20% between 2021 and 2031. The growing demand for non-invasive procedures such as anti-wrinkle chemical peels and others will drive market expansion. Because of the enormous outbreak of COVID-19, the Anti-Aging Products, Services, and Devices Market fell …
Bovine Lactoferrin Market to expand at a 15.8% value CAGR by 2033 | Says FMI Analyst
According to the latest report by Future Market Insights on the global Bovine Lactoferrin Market, the market is expected to register a growth of 15.8% CAGR between 2023 and 2033 With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Bovine Lactoferrin Market. FMI offers insights into the …
Endoscope Reprocessing Device Market Booming Trends, Growth and Forecast by 2032
In 2021, the global endoscope reprocessing device market accounted for approximately 43.4% of the global medical device reprocessing market, which was valued at US$ 3.1 billion. Endoscope reprocessing device sales increased at a CAGR of 6.5% from 2012 to 2021, owing to the rising prevalence of chronic diseases. Furthermore, various original equipment manufacturers and third-party …
Continue reading “Endoscope Reprocessing Device Market Booming Trends, Growth and Forecast by 2032”
Non-Surgical Fat Reduction Expanding R&D Projects to Drive Market Growth
The non-surgical fat reduction market is expected to be worth US$ 1.3 billion by the end of 2022, and to grow at a CAGR of 13.6% to be worth US$ 4.5 billion by 2032. According to a recent study by Future Market Insights, cryolipolysis will lead the global market with a market share of approximately …
Continue reading “Non-Surgical Fat Reduction Expanding R&D Projects to Drive Market Growth”
Flow Cytometry Market Growth, Regional Analysis, Trends and Forecast by 2032
The global Flow Cytometry Market is expected to experience profitable growth at a 7.4% CAGR from 2022 to 2032. The global market is expected to reach a valuation of US$ 5.6 billion by the end of 2022 and nearly US$ 11.4 billion by the end of 2032. According to Future Market Insights’ reports on the …
Continue reading “Flow Cytometry Market Growth, Regional Analysis, Trends and Forecast by 2032”
Adrenogenital Syndrome Treatment Market is expected to garner a value of US$ 22.08 Billion
The global adrenogenital syndrome treatment market is expected to reach $12.81 billion in 2023, with a 5.6% CAGR from 2023 to 2033. Growth is expected to be driven by natural treatments, minimally invasive surgeries, and new therapies. In Austria, newborn screening programmes have been established to detect severe forms of AGS so that affected children …
Abetalipoproteinemia Management Market is projected to reach US$ 341 million by 2033
The global abetalipoproteinemia management market is expected to surpass a valuation of US$ 147 million in 2023 and reach US$ 341 million by 2033, growing at an 8.78% CAGR. During the forecast period, the market for Abetalipoproteinemia will be driven by the rising prevalence of imaging studies such as hepatic scans or ultrasonography to assess …